Highlights and Quick Summary
- Investing cash flow for the quarter ending September 30, 2023 was $20.1 Million (a -71.3% decrease compared to previous quarter)
- Year-over-year quarterly Investing cash flow decreased by -166.72%
- Annual Investing cash flow for 2022 was $-127 Million (a 88.46% increase from previous year)
- Annual Investing cash flow for 2021 was $-67.4 Million (a 3003.5% increase from previous year)
- Annual Investing cash flow for 2020 was $-2.17 Million (a 99.36% increase from previous year)
- Twelve month Investing cash flow ending September 30, 2023 was $32.8 Million (a -149.67% decrease compared to previous quarter)
- Twelve month trailing Investing cash flow decreased by -125.84% year-over-year
Trailing Investing cash flow for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| $32.8 Million | $-66.1 Million | $-147 Million | $-127 Million |
Visit stockrow.com/ABSI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Investing cash flow of Absci Corporation
Most recent Investing cash flowof ABSI including historical data for past 10 years.Interactive Chart of Investing cash flow of Absci Corporation
Absci Corporation Investing cash flow for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $20.14 | $70.15 | $-27.3 | – | – |
| 2022 | $-30.18 | $-78.72 | $-11.22 | $-6.86 | $-126.98 |
| 2021 | $-8.32 | $-6.82 | $-43.37 | $-8.88 | $-67.38 |
| 2020 | $-0.91 | $-0.74 | $-0.34 | $-0.19 | $-2.17 |
| 2019 | $-1.09 | – | – | – | $-1.09 |
Business Profile of Absci Corporation
Sector: Healthcare
Industry: Biotechnology